A rapid, sensitive and versatile two-site immunoradiometric assay for insulin

P C Guest1, C Lowing, S D Arden

  • 1Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, U.K.

Insights

A new, rapid, and highly sensitive two-site immunoradiometric assay for insulin was developed. This assay accurately measures insulin levels in various biological samples, including plasma and islet secretions.

Area of Science:

  • Endocrinology
  • Immunoassay Development
  • Biochemistry

Background:

  • Accurate insulin measurement is crucial for diagnosing and managing diabetes and other metabolic disorders.
  • Existing assays may lack the required speed, sensitivity, or specificity for certain applications.

Purpose of the Study:

  • To develop and validate a novel two-site immunoradiometric assay for insulin.
  • To assess the assay's sensitivity, specificity, reproducibility, and applicability to biological samples.

Main Methods:

  • Utilized a two-site immunoradiometric assay (IRMA) employing a 125I-labelled monoclonal antibody against human proinsulin.
  • Employed immunoprecipitation with an immunoadsorbent from polyclonal antisera against bovine insulin for binding assessment.
  • Tested reactivity with various insulin types and related peptides, and assessed reproducibility using human insulin standards.

Main Results:

  • Achieved a rapid processing time of 60 minutes and a low detection limit of 2 pM.
  • Demonstrated similar reactivity for human, rat, bovine, and porcine insulins.
  • Showed high reproducibility with coefficients of variation of 2.3% and 5.5% at different concentrations.
  • Observed varying but significant reactivity with human insulin-like peptides.

Conclusions:

  • The developed IRMA is both rapid and highly sensitive for insulin quantification.
  • The assay exhibits broad applicability across different species and sample types.
  • This assay is suitable for clinical and research applications, including plasma analysis and in vitro secretion studies.